The landscape of modern physics is undergoing a significant shift as researchers move from observing quantum phenomena to actively engineering…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read More
Cal Poly Researchers Advance Quantum Matter Control Through Flux Switching Floquet Engineering
The landscape of computational science is standing on the precipice of a generational shift as quantum technology moves from theoretical…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read More
University of Basel Researchers Engineer First Fully Human Synthetic Bone Marrow Model to Advance Cancer Research and Reduce Animal Testing
In a landmark achievement for regenerative medicine and oncology, a multidisciplinary team of scientists at the University of Basel and…
Read More
Indiana University Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease Research
In a significant stride for hematological research and regenerative medicine, scientists at the Indiana University School of Medicine have successfully…
Read More
Scientists Engineer Stable Optical Tornadoes in Miniature Structures Using Liquid Crystals and Synthetic Magnetic Fields to Advance Quantum Photonics
In a significant leap for the field of photonics, an international team of researchers has successfully demonstrated the creation of…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Advance Pediatric Diagnostics and National Access
Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a preeminent pediatric research and clinical…
Read More
Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…
Read More
Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical Innovation
Regeneron Pharmaceuticals and Telix Pharmaceuticals have announced a significant partnership aimed at accelerating the development and commercialization of novel radiopharmaceutical…
Read More
